Semaglutide is primarily used for weight loss and diabetes management, while omeprazole is commonly prescribed for acid-related stomach issues
Bielohuby M, Sawitzky M, Johnsen I, et al
Currently, NICE guidance addresses the use of these medications for weight management through specific technology appraisals, though there is limited guidance specifically for post-bariatric weight regain
Clinical trials have not identified hepatotoxicity as a characteristic adverse effect of semaglutide, though rare idiosyncratic reactions cannot be completely excluded
Molecular epidemiology of invasive Haemophilus influenzae disease in Portugal: an update of the post-vaccine period, 2011-2018
Individuals with Wilsons disease (a condition causing copper buildup in the body) or pregnant and breastfeeding women should avoid using Ghk-Cu peptides